tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PTCT Stock Latest News

PTC Therapeutics: Strategic Growth and Market Expansion Drive Buy Rating
RatingsPTC Therapeutics: Strategic Growth and Market Expansion Drive Buy Rating
6d ago
PTCT
PTC Therapeutics upgraded to Buy from Neutral at BofA
PremiumThe Fly
PTC Therapeutics upgraded to Buy from Neutral at BofA
11d ago
PTCT
PTC Therapeutics price target lowered to $42 from $56 at Barclays
PremiumThe Fly
PTC Therapeutics price target lowered to $42 from $56 at Barclays
11d ago
PTCT
PTC Therapeutics’ Earnings Call: Strong Start to 2025
PremiumCompany Announcements
PTC Therapeutics’ Earnings Call: Strong Start to 2025
12d ago
PTCT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
12d ago
MRK
ATHE
PTC Therapeutics price target lowered to $66 from $70 at Baird
PremiumThe FlyPTC Therapeutics price target lowered to $66 from $70 at Baird
12d ago
PTCT
PTC Therapeutics: Strong Revenue Performance and Promising Pipeline Present Compelling Buy Opportunity
Premium
Ratings
PTC Therapeutics: Strong Revenue Performance and Promising Pipeline Present Compelling Buy Opportunity
12d ago
PTCT
PTC Therapeutics price target lowered to $67 from $75 at JPMorgan
Premium
The Fly
PTC Therapeutics price target lowered to $67 from $75 at JPMorgan
12d ago
PTCT
PTC Therapeutics: Strong Financial Performance and Promising Product Launches Justify Buy Rating
PremiumRatings
PTC Therapeutics: Strong Financial Performance and Promising Product Launches Justify Buy Rating
12d ago
PTCT
PTC Therapeutics upgraded to Neutral from Sell at Citi
PremiumThe Fly
PTC Therapeutics upgraded to Neutral from Sell at Citi
12d ago
PTCT
PTC Therapeutics Reports Strong Q1 2025 Results
PremiumCompany Announcements
PTC Therapeutics Reports Strong Q1 2025 Results
12d ago
PTCT
PTC Therapeutics: Balancing Strategic Success with Regulatory Uncertainty – A Hold Rating Analysis
PremiumRatings
PTC Therapeutics: Balancing Strategic Success with Regulatory Uncertainty – A Hold Rating Analysis
13d ago
PTCT
PTC Therapeutics Reports Strong Q1 2025 Financial Results
PremiumCompany AnnouncementsPTC Therapeutics Reports Strong Q1 2025 Financial Results
13d ago
8K
PTCT
PTC Therapeutics narrows FY25 revenue view to $650M-$800M from $600M-$800M
Premium
The Fly
PTC Therapeutics narrows FY25 revenue view to $650M-$800M from $600M-$800M
13d ago
PTCT
PTC Therapeutics reports Q1 EPS $10.04 may not compare with consensus (7c)
Premium
The Fly
PTC Therapeutics reports Q1 EPS $10.04 may not compare with consensus (7c)
13d ago
PTCT
Controversial doctor Vinay Prasad named CBER director, STAT reports
PremiumThe Fly
Controversial doctor Vinay Prasad named CBER director, STAT reports
13d ago
DYN
RNA
Optimistic Buy Rating for PTC Therapeutics Amid Market Skepticism and Promising Stage 2 Data
PremiumRatings
Optimistic Buy Rating for PTC Therapeutics Amid Market Skepticism and Promising Stage 2 Data
13d ago
PTCT
Hold Rating for PTC Therapeutics Amid Mixed Clinical Results and Uncertain FDA Approval Prospects
PremiumRatings
Hold Rating for PTC Therapeutics Amid Mixed Clinical Results and Uncertain FDA Approval Prospects
13d ago
PTCT
PTC Therapeutics price target lowered to $57 from $65 at RBC Capital
PremiumThe Fly
PTC Therapeutics price target lowered to $57 from $65 at RBC Capital
14d ago
PTCT
PTC data ‘brought more confusion than answers,’ says Citi
PremiumThe FlyPTC data ‘brought more confusion than answers,’ says Citi
14d ago
PTCT
PTC Therapeutics Reports Positive Phase 2 Study Results
Premium
Company Announcements
PTC Therapeutics Reports Positive Phase 2 Study Results
14d ago
8K
PTCT
PTC Therapeutics’ PTC518 achieves primary endpoint in Phase 2 Huntington’s study
Premium
The Fly
PTC Therapeutics’ PTC518 achieves primary endpoint in Phase 2 Huntington’s study
14d ago
PTCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >